Cargando…
C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target?
Autor principal: | Pepys, Mark B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083631/ https://www.ncbi.nlm.nih.gov/pubmed/33778886 http://dx.doi.org/10.1093/eurheartj/ehab169 |
Ejemplares similares
-
C-reactive protein and clinical outcomes in patients with COVID-19
por: Smilowitz, Nathaniel R, et al.
Publicado: (2021) -
Lack of Effect of a Single Injection of Human C-Reactive Protein on Murine Lupus or Nephrotoxic Nephritis
por: Carlucci, Francesco, et al.
Publicado: (2010) -
New therapeutic perspectives – amyloid removal
por: Pepys, Mark
Publicado: (2015) -
C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction
por: Griselli, M., et al.
Publicado: (1999) -
ROLE OF COMPLEMENT IN INDUCTION OF ANTIBODY PRODUCTION IN VIVO : EFFECT OF COBRA FACTOR AND OTHER C3-REACTIVE AGENTS ON THYMUS-DEPENDENT AND THYMUS-INDEPENDENT ANTIBODY RESPONSES
por: Pepys, M. B.
Publicado: (1974)